The global endoscopic clips market is experiencing significant growth, driven by factors such as the increasing prevalence of gastrointestinal disorders, advancements in minimally invasive surgical procedures, and supportive government initiatives aimed at enhancing healthcare infrastructure and awareness. The global endoscopic clips market is valued at US$ 487.5 million in 2023 and is forecasted to secure a revenue of US$ 997.2 million by 2033-end. Worldwide endoscopic clip sales are estimated to increase at 7.4% CAGR across the forecast period (2023 to 2033). Gastrointestinal disorders, including colorectal cancers, gastroesophageal reflux disease (GERD), inflammatory bowel disease, and irritable bowel syndrome, are becoming increasingly common worldwide. For instance, nearly 20% of the U.S. population is affected by GERD. This rising burden underscores the need for effective diagnostic and therapeutic tools, thereby bolstering the demand for endoscopic clips. ​

Government initiatives aimed at promoting healthcare infrastructure development and raising awareness about gastrointestinal health are further propelling market growth. Additionally, patient preference is shifting towards minimally invasive surgeries due to benefits such as reduced recovery times and shorter hospital stays. Endoscopic clips play a crucial role in these procedures by providing low-cost solutions with better access to lesions, which enhances their adoption in clinical settings. ​

The market is also influenced by the increasing number of endoscopic procedures performed globally, the rising incidence of obesity, an expanding geriatric population, and continuous technological advancements in medical equipment. However, challenges such as potential side effects associated with endoscopic clips, including rectal bleeding and abdominal pain, as well as stringent regulatory standards governing product approval, may hinder market growth. ​

In terms of market segmentation, endoscopic clips are primarily utilized for applications such as hemostasis, endoscopic marking, and others. The hemostasis segment, which involves stopping bleeding in the gastrointestinal tract, is expected to witness significant growth, with shipments projected to increase at a CAGR of 7.5% over the next decade. This growth is attributed to the rising prevalence of gastrointestinal bleeding disorders. ​

Geographically, North America holds a prominent position in the endoscopic clips market, with an anticipated growth rate of 7% CAGR from 2023 to 2033. This can be attributed to factors such as a well-established healthcare infrastructure, favorable reimbursement policies, and a high prevalence of gastrointestinal disorders. In Europe, poor lifestyle choices and a rising prevalence of obesity are contributing to increased demand for endoscopic clips. Meanwhile, Japan's expanding elderly population presents lucrative opportunities for market players, as aging is associated with a higher incidence of gastrointestinal issues. ​

The competitive landscape of the endoscopic clips market features key players such as CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Cook Medical, Olympus Corporation, and Medtronic. These companies are focusing on product innovation and strategic partnerships to strengthen their market positions. For example, in March 2022, MicroPort Urocare Medical Technology received marketing approval for its Ruyi Clip, a single-use hemostatic clip device, from China's National Medical Products Administration. Similarly, in January 2022, Cook Medical unveiled its Instinct Plus Endoscopic Clipping Device with enhanced functionality and extended indications.

The report also highlights key opportunities in the market, including the growing demand for minimally invasive procedures and the rising incidence of gastrointestinal bleeding disorders. It addresses critical questions such as the projected market size and growth rate, factors driving sales, and the competitive landscape. Overall, the endoscopic clips market is poised for substantial growth, driven by technological advancements, increasing disease prevalence, and evolving patient preferences.

Read more -

Fact.MR forecasts the global carglumic acid market to grow from US$ 152.5 million in 2023 to US$ 314.4 million in 2033. This represents a CAGR of over 7.5% from 2023 to 2033.

The global metal finishing chemicals market is estimated at USD 11.7 Billion in 2022 and is forecast to surpass USD 16.4 Billion by 2032, growing at a CAGR of 3.4% from 2022 to 2032.

Based on the analysis by Fact.MR, the global perfluorocarbons market is estimated to reach a valuation of US$ 1.0 billion in 2023 and it is expected to grow at a CAGR of 4.0% to reach US$ 1.5 billion by the end of 2033.

The global anti-infective agents market is expected to be worth US$ 141 Billion in fiscal year 2022, up from US$ 136 Billion in fiscal year 2021. From 2022 to 2032, the market is expected to grow at a 3.3% CAGR, reaching a value of US$ 195.8 Billion by the end of 2032.

Polycarbonate resins market is anticipated to register a volume CAGR of over 4% during the forecast period, 2019 to 2029.

Global demand for nylon is valued at US$ 34.1 billion in 2023 and is extrapolated to attain a market revenue of US$ 60.5 billion by 2033-end. The global nylon market is projected to exhibit expansion at a healthy 5.9% CAGR over the next ten years.